« BackAnnals of Emergency Medicine
Article in Press

Is Continuous Nebulized β-Agonist Therapy More Effective Than Intermittent β-Agonist Therapy at Reducing Hospital Admissions in Acute Asthma?

Synergy Medical Education Alliance, Central Michigan University College of Human Medicine, Saginaw, MI

published online 06 January 2012.
Corrected Proof

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 EBEM Commentators

 This is a clinical synopsis, a regular feature of the Annals' Systematic Review Snapshot (SRS) series. The source for this systematic review snapshot is: Camargo CA Jr, Spooner C, Rowe BH. Continuous versus intermittent beta-agonists for acute asthma. Cochrane Database Syst Rev. 2011;(4):CD001115. doi:10.1002/14651858. CD001115. The Annals EBEM editors assisted in the preparation of the abstract of this Cochrane systematic review.

 Systematic Review Author Contact

 Carlos A. Camargo Jr, MD, DrPH

 Department of Emergency Medicine

 Massachusetts General Hospital

 Boston, MA

 E-mail: ccamargopartners.org

PII: S0196-0644(11)01878-6

doi:10.1016/j.annemergmed.2011.11.037

« BackAnnals of Emergency Medicine

Article Tools